Cargando…

Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC

As the most invasive and lethal subtype of breast cancer (BC), triple-negative breast carcinoma (TNBC) is of increasing interest. However, the androgen receptor (AR) still has an unclear role in TNBC. The current study is aimed at testing the diagnostic and therapeutic performance of novel biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qiaonan, Qiu, Pengjun, Yao, Qingzhi, Chen, Jianpeng, Lin, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493148/ https://www.ncbi.nlm.nih.gov/pubmed/36157217 http://dx.doi.org/10.1155/2022/4964793

Ejemplares similares

Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2021)

Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
por: Qiu, Pengjun, et al.
Publicado: (2021)

A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2022)

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
por: Yang, Dan, et al.
Publicado: (2020)

An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer
por: Qiu, Pengjun, et al.
Publicado: (2022)

Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer
por: Guo, Qiaonan, et al.
Publicado: (2023)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related long non-coding RNA signature and personalized therapeutic strategy of breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2022)

Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma
por: Fan, Rong, et al.
Publicado: (2021)

Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
por: Tian, Rui, et al.
Publicado: (2022)

Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
por: Yang, Wanli, et al.
Publicado: (2019)

Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis
por: Zeng, Yu, et al.
Publicado: (2021)

Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study
por: Bai, Henan, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction
por: Yang, Jingjin, et al.
Publicado: (2023)

Retracted: Hub Gene Screening Associated with Early Glaucoma: An Integrated Bioinformatics Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining
por: Tang, Lan, et al.
Publicado: (2023)

Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis
por: Chen, Xiaolong, et al.
Publicado: (2021)

Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer
por: Lu, Si, et al.
Publicado: (2020)

Retracted: Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells
por: Liu, Huiyong, et al.
Publicado: (2020)

Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics
por: Liu, Yang, et al.
Publicado: (2022)

Hub genes, diagnostic model, and predicted drugs in systemic sclerosis by integrated bioinformatics analysis
por: Yan, Yue-Mei, et al.
Publicado: (2023)

Bioinformatic screening and identification of downregulated hub genes in adrenocortical carcinoma
por: Xu, Fangshi, et al.
Publicado: (2020)

Screening and verification of hub genes involved in osteoarthritis using bioinformatics
por: Xie, Junxiong, et al.
Publicado: (2021)

Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses
por: Liu, Zhendong, et al.
Publicado: (2020)

Bioinformatic Exploration of Hub Genes and Potential Therapeutic Drugs for Endothelial Dysfunction in Hypoxic Pulmonary Hypertension
por: Chen, Ai, et al.
Publicado: (2022)

Identification of hub genes in gastric cancer by integrated bioinformatics analysis
por: Sun, Feng, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients
por: Li, Xiaofeng, et al.
Publicado: (2022)

Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis
por: Zeng, Yu, et al.
Publicado: (2020)

Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis
por: Nayak, Chirasmita, et al.
Publicado: (2022)

An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia
por: Liu, Keling, et al.
Publicado: (2019)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis
por: Hao, Mingqian, et al.
Publicado: (2020)

Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis
por: Huang, Yongming, et al.
Publicado: (2022)

Screening the hub genes and analyzing the mechanisms in discharged COVID‐19 patients retesting positive through bioinformatics analysis
por: Fang, Ke‐Ying, et al.
Publicado: (2022)

Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis
por: Lu, Xiao-Qing, et al.
Publicado: (2021)

Uncovering hub genes in sepsis through bioinformatics analysis
por: Liu, Zhao, et al.
Publicado: (2023)

Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019
por: Wang, Ting, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis of Hub Genes and Pathways in Anaplastic Thyroid Carcinomas
por: Gao, Xueren, et al.
Publicado: (2019)

Integrated bioinformatics analysis to identify 15 hub genes in breast cancer
por: Jin, Haoxuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6en9i7bu5aeg2e1tufenm0tjek